AMWC China 2025 | Hyamax Wins Annual Injectable Product Award

We are proud to announce that Hyamax® HA+ Volumizer (V) has been honored with the “Annual Injectable Product Award” at the prestigious AMWC China 2025 conference! 🎉

This recognition highlights Hyamax’s continuous pursuit of scientific excellence and aesthetic precision.

Powered by CD™ Cross-Linking Technology, HA+ (V) features a dense and uniform honeycomb molecular structure that ensures exceptional elasticity, stability, and long-lasting support — maintaining its shape and integrity for up to 12 months.

Aligned with Hyamax’s “Precise & Minimal” injection philosophy, this product is designed to prevent overfilling, ensuring a natural, balanced, and safe beauty experience. By addressing the prevalent concern of jawline under development in Asian facial profiles, Hyamax® HA+ (V) fills a crucial gap in the market for clinically reliable and anatomically precise injectable solutions.

Adding to this milestone, the same product has also received MDR (Medical Device Regulation) certification in 2025, representing one of the highest global standards in medical device safety, performance, and clinical efficacy.

This certification reinforces our commitment to providing world-class, compliant, and scientifically validated aesthetic injectables trusted worldwide. 🌍

*About MDR Certification

The European Union MDR (Medical Device Regulation) certification is recognized as one of the world’s most stringent regulatory standards. It ensures that medical devices meet the highest requirements in safety, traceability, and clinical effectiveness, symbolizing global trust and quality excellence.